Bellerophon Therapeutics, Inc. Accrued Liabilities, Current
Bellerophon Therapeutics, Inc. had Accrued Liabilities, Current of $1.38 million as of 2020-09-30, per its 10-Q filed 2020-11-05.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:AccruedLiabilitiesCurrent · last filed 2020-11-05
- 2020-09-30: Accrued Liabilities, Current $1.38M.
- 2020-06-30: Accrued Liabilities, Current $1.22M.
- 2020-03-31: Accrued Liabilities, Current $2.10M.
- 2019-12-31: Accrued Liabilities, Current $1.70M.
| Period end | Accrued Liabilities, Current | Accrued Liabilities, Current as first filed |
|---|---|---|
| 2020-09-30 | $1.38M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $1.22M 10-Q · filed 2020-08-05 | |
| 2020-03-31 | $2.10M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $1.70M 10-Q · filed 2020-11-05 | |
| 2019-09-30 | $1.49M 10-Q · filed 2019-11-06 | |
| 2019-06-30 | $752.00K 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $885.00K 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $1.01M 10-K · filed 2020-04-06 | |
| 2018-09-30 | $880.00K 10-Q · filed 2018-11-07 | |
| 2018-06-30 | $905.00K 10-Q · filed 2018-08-01 | |
| 2018-03-31 | $816.00K 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $1.44M 10-K · filed 2019-03-14 | |
| 2017-09-30 | $1.78M 10-Q · filed 2017-11-07 | |
| 2017-06-30 | $838.00K 10-Q · filed 2017-08-07 | |
| 2017-03-31 | $717.00K 10-Q · filed 2017-05-15 | |
| 2016-12-31 | $1.11M 10-K · filed 2018-03-15 | $922.00K 10-K · filed 2017-03-13 |
| 2016-09-30 | $1.30M 10-Q · filed 2016-11-08 | |
| 2016-06-30 | $1.67M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $3.04M 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $2.23M 10-K · filed 2017-03-13 | $3.49M 10-K · filed 2016-03-21 |
| 2015-09-30 | $3.44M 10-Q · filed 2015-11-12 | |
| 2015-06-30 | $2.83M 10-Q · filed 2015-08-14 | |
| 2015-03-31 | $3.83M 10-Q · filed 2015-05-15 | |
| 2014-12-31 | $2.75M 10-K · filed 2016-03-21 |